Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › ALEXANDRIA › RAPIDES HEALTHCARE SYSTEM, L.L.C.

RAPIDES HEALTHCARE SYSTEM, L.L.C.

NPI: 1477500015 · ALEXANDRIA, LA 71301 · General Acute Care Hospital · NPI assigned 05/28/2006

$26.89M
Total Medicaid Paid
1,128,412
Total Claims
1,003,242
Beneficiaries
231
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDAVIS, DANIEL (CFO)
NPI Enumeration Date05/28/2006

Related Entities

Other providers sharing the same authorized official: DAVIS, DANIEL

ProviderCityStateTotal Paid
HCA HEALTH SERVICES OF OKLAHOMA INC OKLAHOMA CITY OK $692K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 170,656 $3.78M
2019 170,409 $3.98M
2020 115,973 $2.71M
2021 146,172 $3.27M
2022 189,363 $4.45M
2023 183,201 $4.55M
2024 152,638 $4.15M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 111,960 103,660 $4.51M
99284 Emergency department visit for the evaluation and management, high severity 78,836 71,069 $4.38M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,379 2,187 $1.96M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 50,503 45,358 $1.71M
70450 Computed tomography, head or brain; without contrast material 6,576 5,827 $1.40M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 15,480 13,612 $983K
85027 129,771 114,946 $638K
J7030 Infusion, normal saline solution , 1000 cc 17,669 15,750 $633K
71046 Radiologic examination, chest; 2 views 13,909 12,927 $625K
87631 4,915 4,478 $615K
80053 Comprehensive metabolic panel 70,938 63,690 $575K
71045 Radiologic examination, chest; single view 25,024 22,274 $511K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 10,714 9,506 $505K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 32,210 28,432 $464K
76818 2,365 1,526 $379K
J0696 Injection, ceftriaxone sodium, per 250 mg 4,848 4,451 $348K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 10,493 9,600 $335K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 10,487 9,599 $335K
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,891 6,894 $258K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 2,147 2,012 $249K
84443 Thyroid stimulating hormone (TSH) 16,578 15,092 $225K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 2,107 1,964 $223K
G0378 Hospital observation service, per hour 1,975 1,290 $219K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,054 5,628 $192K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,866 3,637 $182K
74150 528 478 $174K
81001 68,607 60,578 $162K
84484 20,467 17,284 $158K
87086 Culture, bacterial; quantitative colony count, urine 19,623 17,773 $136K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,432 4,039 $135K
80048 Basic metabolic panel (calcium, ionized) 19,602 17,842 $133K
80061 Lipid panel 11,964 10,994 $130K
36415 Collection of venous blood by venipuncture 51,046 45,258 $128K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,629 1,290 $103K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4,959 4,503 $102K
74018 3,299 3,012 $98K
83036 Hemoglobin; glycosylated (A1C) 12,086 11,112 $91K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,188 1,922 $90K
80076 12,996 12,013 $89K
94060 696 661 $87K
86738 6,867 6,372 $87K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 4,435 3,960 $86K
76801 1,002 898 $84K
81025 12,624 11,622 $82K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 7,361 4,410 $76K
J7120 Ringers lactate infusion, up to 1000 cc 2,209 1,901 $73K
87653 2,150 2,020 $72K
99281 Emergency department visit for the evaluation and management, self-limited or minor 5,476 5,040 $69K
77067 Screening mammography, bilateral, including computer-aided detection 1,772 1,708 $66K
0240U 833 774 $63K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2,154 1,891 $59K
80074 1,474 1,341 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,626 1,478 $57K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 10,438 8,683 $57K
73562 1,307 1,205 $57K
20610 2,106 1,856 $56K
83690 9,645 8,878 $55K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,685 3,503 $54K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 505 445 $50K
87808 3,830 3,491 $48K
83735 9,755 8,753 $46K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 537 516 $44K
87070 5,122 4,816 $43K
84439 5,946 5,413 $43K
83605 5,735 4,738 $43K
83874 6,153 5,306 $40K
72125 Computed tomography, cervical spine; without contrast material 164 156 $38K
82553 5,566 4,704 $38K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 515 504 $36K
86803 3,045 2,725 $35K
59025 Fetal non-stress test 297 259 $35K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,201 1,110 $34K
84703 5,254 4,787 $32K
87340 3,752 3,363 $32K
96375 Therapeutic injection; each additional sequential IV push 2,975 2,478 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 10,822 9,092 $30K
94729 413 393 $30K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 937 906 $28K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,105 818 $27K
94726 325 308 $27K
83655 2,107 2,009 $26K
83880 1,185 1,070 $25K
86592 6,298 5,693 $25K
73630 745 635 $25K
86308 4,505 4,246 $23K
87400 1,562 1,333 $23K
87390 998 931 $19K
84146 1,144 1,022 $19K
J7050 Infusion, normal saline solution, 250 cc 808 661 $18K
80047 2,398 2,121 $17K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 41 40 $15K
85610 6,172 5,435 $15K
82731 723 644 $15K
74176 Computed tomography, abdomen and pelvis; without contrast material 14 14 $14K
84425 604 579 $13K
86703 1,173 1,096 $12K
87040 1,236 1,034 $12K
85730 3,613 3,153 $12K
73610 342 289 $11K
82607 832 778 $11K
84702 856 764 $11K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 88 62 $11K
87077 991 936 $9K
76705 Ultrasound, abdominal, real time with image documentation; limited 121 108 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete 56 54 $8K
C1892 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away 94 84 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 532 272 $8K
86850 2,357 2,013 $8K
81003 3,248 2,349 $7K
82550 1,747 1,557 $7K
86762 570 506 $7K
87205 1,731 1,563 $7K
73130 189 137 $6K
84112 80 71 $6K
76830 Ultrasound, transvaginal 60 53 $6K
73110 146 106 $6K
86901 3,127 2,681 $5K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 1,724 1,519 $5K
86900 3,111 2,664 $5K
90686 1,417 1,248 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,197 6,384 $5K
87905 596 493 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 6,243 5,170 $4K
82150 808 742 $4K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 1,284 1,049 $4K
72131 14 12 $4K
C1769 Guide wire 180 160 $3K
86140 651 609 $3K
86694 169 141 $3K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 14 13 $3K
80164 226 182 $2K
82043 435 421 $2K
77063 Screening digital breast tomosynthesis, bilateral 609 569 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 2,440 2,099 $2K
84481 278 251 $2K
Q0222 Injection, bebtelovimab, 175 mg 21 14 $2K
87634 37 36 $2K
82570 435 418 $2K
82746 210 176 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 2,071 1,760 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 727 660 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 46 41 $2K
94727 27 26 $2K
72100 56 51 $2K
83001 122 113 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 78 68 $2K
J2270 Injection, morphine sulfate, up to 10 mg 2,206 1,893 $2K
87186 208 187 $2K
82077 187 158 $2K
86787 162 139 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 56 51 $1K
77336 45 13 $1K
70100 67 55 $1K
J1170 Injection, hydromorphone, up to 4 mg 138 112 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 107 89 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 6,278 3,988 $985.65
73030 27 27 $915.67
84134 169 153 $870.44
86235 15 13 $850.51
82950 195 181 $800.81
84145 29 27 $667.47
80179 59 50 $579.96
84153 37 37 $557.62
58100 95 88 $556.60
83970 13 13 $544.94
72040 13 13 $516.58
83615 105 74 $514.44
87501 48 36 $471.06
90715 14 12 $458.64
87276 36 27 $434.54
87529 15 13 $423.88
87299 37 27 $417.12
85652 197 181 $415.78
82652 53 51 $415.32
96361 Intravenous infusion, hydration; each additional hour 237 193 $401.16
87260 36 27 $399.71
84550 100 76 $394.21
87280 36 27 $378.24
82248 115 91 $376.06
87275 36 27 $359.95
86141 45 24 $338.48
J2765 Injection, metoclopramide hcl, up to 10 mg 88 83 $320.20
S0028 Injection, famotidine, 20 mg 107 42 $312.36
92133 192 170 $311.25
J0500 Injection, dicyclomine hcl, up to 20 mg 16 13 $310.27
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 526 489 $289.41
84403 12 12 $287.55
82670 13 12 $283.88
84402 12 12 $283.74
87081 57 54 $277.09
J3010 Injection, fentanyl citrate, 0.1 mg 801 624 $242.26
85014 104 97 $235.96
85018 101 94 $227.91
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 64 56 $219.90
J2250 Injection, midazolam hydrochloride, per 1 mg 413 311 $195.46
87279 73 27 $188.81
J8540 Dexamethasone, oral, 0.25 mg 163 140 $187.88
83516 15 13 $161.74
85045 44 40 $156.81
82728 15 12 $152.09
J1644 Injection, heparin sodium, per 1000 units 79 69 $151.71
86038 14 12 $151.31
57454 36 28 $147.50
86039 18 14 $147.28
82247 40 26 $118.14
90714 16 13 $102.20
J0690 Injection, cefazolin sodium, 500 mg 106 30 $99.15
84480 12 12 $85.88
82270 32 13 $85.18
S0077 Injection, clindamycin phosphate, 300 mg 29 29 $75.78
86431 13 13 $74.92
84270 12 12 $69.48
84436 12 12 $64.24
83540 13 12 $57.06
84100 13 12 $56.97
J2360 Injection, orphenadrine citrate, up to 60 mg 36 30 $40.92
J2704 Injection, propofol, 10 mg 503 365 $37.41
G0008 Administration of influenza virus vaccine 1,928 1,521 $28.95
J3480 Injection, potassium chloride, per 2 meq 51 26 $26.91
J2550 Injection, promethazine hcl, up to 50 mg 44 42 $25.70
J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg 33 31 $18.35
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 13 12 $14.43
J2175 Injection, meperidine hydrochloride, per 100 mg 22 17 $14.19
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 14 13 $9.38
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 54 51 $6.64
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 29 24 $4.91
Q0243 Injection, casirivimab and imdevimab, 2400 mg 107 76 $0.00
92015 Determination of refractive state 39 33 $0.00
92134 15 13 $0.00
A9270 Non-covered item or service 324 161 $0.00
87632 69 69 $0.00